Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study

por Schauwvlieghe, A. M. E., Dijkman, G., Hooymans, J. M., Verbraak, F. D., Hoyng, C. B., Dijkgraaf, M. G. W., Peto, T., Vingerling, J. R., Schlingemann, R. O.
Publicado 2016

Stopping antibiotic therapy after 72 h in patients with febrile neutropenia following intensive chemotherapy for AML/MDS (safe study): A retrospective comparative cohort study

por Schauwvlieghe, A., Dunbar, A., Storme, E., Vlak, A., Aerts, R., Maertens, J., Sciot, B., Van Der Wel, T., Papageorgiou, G., Moors, I., Cornelissen, J.J., Rijnders, B.J.A., Mercier, T.
Publicado 2021

Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study)

por Schauwvlieghe, A.M.E., Dijkman, G., Hooymans, J.M., Verbraak, F.D., Hoyng, C.B., Dijkgraaf, M.G.W., Van Leeuwen, R., Vingerling, J.R., Moll, A.C., Schlingemann, Reinier O.
Publicado 2015